News Releases

News and information from The Leukemia & Lymphoma Society

EHE International Showcases LLS

New York, Jan. 4, 2016 – EHE International will ring in the new year supporting blood cancer awareness, featuring The Leukemia & Lymphoma Society® (LLS) in a window display at 10 Rockefeller Center, in New York City, throughout January. Photos featuring eight blood cancer survivors, including adults, children and their families, are displayed with facts about LLS’s impact in funding research to advance lifes...

Burlington Stores & LLS Raise More Than $25 Million for Blood Cancer Research

Burlington’s 2015 campaign raised more than $3 million for life-saving research White Plains, NY (December 17, 2015) – Burlington Stores and The Leukemia & Lymphoma Society’s (LLS) Light The Night® campaign were pleased to partner for the 14th consecutive year this past fall, to shine a light on the urgent need for funding to help support blood cancer research and advance new treatments for cures. From ...

New Therapies for Blood Cancers Emerging at Stunning Pace

White Plains, NY – December 15, 2015 – For the more than one million Americans living with or in remission from a blood cancer, there is more hope than ever for new treatments and even cures, not someday, but today. Clinical findings presented at the 57th American Society of Hematology (ASH) Annual Meeting, in Orlando, December 5-8, made it increasingly clear that new discoveries in precision medicine and immu...

LLS Continues to Lead the Way to Cures and Access for Blood Cancer Patients

White Plains, NY – December 3, 2015 – The Leukemia & Lymphoma Society (LLS) further solidifies its leadership role in finding cures and ensuring access to treatments for patients with blood cancers, with the announcement of significant research advances and patient support programs: More than 100 LLS-funded researchers will share their findings at the 57th American Society of Hematology (ASH) Annual Mee...

Two Myeloma Drugs Win Approval Building Hope for Blood Cancer Patients

White Plains, NY – November 23, 2015 – The Leukemia & Lymphoma Society (LLS) applauds the FDA’s recent approval of two new drugs -- daratumumab and ixazomib -- to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S.  Advances in treatments for many different types of blood cancers a...

Unitio and LLS Partner to Create Online Patient-Caregiver Community

November 2, 2015 – Unitio, Inc., a Boston-based nonprofit organization, and The Leukemia & Lymphoma Society (LLS) today announced a partnership to develop an online patient community that will bring together those affected by blood cancers to share real world experiences and contribute to vital research. This partnership marks the first endeavor in cancer for Unitio, a-first-of-its-kind nonprofit designed to un...

LLS Commits $28.6 Million to New Cancer Research Funding

View full multi-media release with videos and photos here. White Plains, N.Y. (September 30, 2015) – The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderso...

Sarah Cannon Blood Cancer Network Lights The Night To Advance Blood Cancer Care

Contact: Kristin Hoose
(914) 821-8973
kristin.hoose@lls.org -Sarah Cannon and The Leukemia & Lymphoma Society Join Forces
to Redefine Cancer Treatment Landscape- White Plains, NY and Nashville, TN (September 22, 2015) – The Sarah Cannon Blood Cancer Network, one of the largest providers of care for blood cancer patients, has expanded its partnership with The Leukemia &a...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: